CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer

Breast cancer (BC) is a leading cause of cancer-related death in women. Adjuvant systemic chemotherapies are effective in reducing risks of recurrence and have contributed to reduced BC mortality. Although targeted adjuvant treatments determined by biomarkers for endocrine and HER2-directed therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Xinyu, Apple, Sophia, Zhao, Hong, Song, Jeongyoon, Lee, Minna, Luo, William, Wu, Xiancheng, Chung, Debra, Pietras, Richard J., Chang, Helena R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503533/
https://www.ncbi.nlm.nih.gov/pubmed/28418843
http://dx.doi.org/10.18632/oncotarget.16203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503533/
https://www.ncbi.nlm.nih.gov/pubmed/28418843
http://dx.doi.org/10.18632/oncotarget.16203

Ejemplares similares